Guidance for post-discharge care following acute kidney injury: an appropriateness ratings evaluation.
acute kidney injury
general practice
heart failure
patient discharge
primary health care
Journal
BJGP open
ISSN: 2398-3795
Titre abrégé: BJGP Open
Pays: England
ID NLM: 101713531
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
06
02
2020
accepted:
10
02
2020
pubmed:
18
6
2020
medline:
18
6
2020
entrez:
18
6
2020
Statut:
epublish
Résumé
Acute kidney injury (AKI) is associated with poor health outcomes, including increased mortality and rehospitalisation. National policy and patient safety drivers have targeted AKI as an example to ensure safer transitions of care. To establish guidance to promote high-quality transitions of care for adults following episodes of illness complicated by AKI. An appropriateness ratings evaluation was undertaken using the RAND/UCLA Appropriateness Method (RAM). The Royal College of General Practitioners (RCGP) AKI working group developed a range of clinical scenarios to help identify the necessary steps to be taken following discharge of a patient from secondary care into primary care in the UK. A 10-person expert panel was convened to rate 819 clinical scenarios, testing the most appropriate time and action following hospital discharge. Specifically, the scenarios focused on determining the appropriateness and urgency for planning: an initial medication review; monitoring of kidney function; and assessment for albuminuria. Taking no action (that is, no medication review; no kidney monitoring; or no albuminuria testing) was rated inappropriate in all cases. In most scenarios, there was consensus that both the initial medication review and kidney function monitoring should take place within 1-2 weeks or 1 month, depending on clinical context. However, patients with heart failure and poor kidney recovery were rated to require expedited review. There was consensus that assessment for albuminuria should take place at 3 months after discharge following AKI. Systems to support tailored and timely post-AKI discharge care are required, especially in high-risk populations, such as people with heart failure.
Sections du résumé
BACKGROUND
BACKGROUND
Acute kidney injury (AKI) is associated with poor health outcomes, including increased mortality and rehospitalisation. National policy and patient safety drivers have targeted AKI as an example to ensure safer transitions of care.
AIM
OBJECTIVE
To establish guidance to promote high-quality transitions of care for adults following episodes of illness complicated by AKI.
DESIGN & SETTING
METHODS
An appropriateness ratings evaluation was undertaken using the RAND/UCLA Appropriateness Method (RAM). The Royal College of General Practitioners (RCGP) AKI working group developed a range of clinical scenarios to help identify the necessary steps to be taken following discharge of a patient from secondary care into primary care in the UK.
METHOD
METHODS
A 10-person expert panel was convened to rate 819 clinical scenarios, testing the most appropriate time and action following hospital discharge. Specifically, the scenarios focused on determining the appropriateness and urgency for planning: an initial medication review; monitoring of kidney function; and assessment for albuminuria.
RESULTS
RESULTS
Taking no action (that is, no medication review; no kidney monitoring; or no albuminuria testing) was rated inappropriate in all cases. In most scenarios, there was consensus that both the initial medication review and kidney function monitoring should take place within 1-2 weeks or 1 month, depending on clinical context. However, patients with heart failure and poor kidney recovery were rated to require expedited review. There was consensus that assessment for albuminuria should take place at 3 months after discharge following AKI.
CONCLUSION
CONCLUSIONS
Systems to support tailored and timely post-AKI discharge care are required, especially in high-risk populations, such as people with heart failure.
Identifiants
pubmed: 32546580
pii: bjgpopen20X101054
doi: 10.3399/bjgpopen20X101054
pmc: PMC7465579
pii:
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
Copyright © 2020, The Authors.
Références
BMJ. 2015 Jan 20;350:h176
pubmed: 25646760
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
J Eval Clin Pract. 2013 Feb;19(1):76-9
pubmed: 21999337
Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1015-23
pubmed: 24742481
Br J Gen Pract. 2011 Aug;61(589):e526-36
pubmed: 21801572
Circulation. 2018 May 8;137(19):2016-2028
pubmed: 29352071
BMJ. 2014 Jul 09;349:g4454
pubmed: 25008352
Semin Arthritis Rheum. 2011 Oct;41(2):95-105
pubmed: 21420149
J Am Soc Nephrol. 2019 Mar;30(3):505-515
pubmed: 31058607
Kidney Int. 2019 Jan;95(1):160-172
pubmed: 30473140
Proc SIGCHI Conf Hum Factor Comput Syst. 2016 May;2016:5324-5336
pubmed: 27500285
Br J Gen Pract. 2013 Apr;63(609):173-4
pubmed: 23540451
BMJ. 2019 Apr 12;365:l1657
pubmed: 30979699
Br J Gen Pract. 2018 Aug;68(673):e512-e523
pubmed: 30012811
BMJ Open. 2016 Oct 11;6(10):e012865
pubmed: 27729353
BMJ Evid Based Med. 2018 Feb;23(1):1-3
pubmed: 29367314
Clin J Am Soc Nephrol. 2013 Feb;8(2):194-202
pubmed: 23124779
Sociol Health Illn. 2019 Jun;41(5):882-899
pubmed: 30756403
BMJ Evid Based Med. 2019 Oct;24(5):170-173
pubmed: 30962252
Kidney Int. 2012 Mar;81(5):477-85
pubmed: 22157656
BMJ. 2018 Nov 28;363:k4666
pubmed: 30487169
BMC Nephrol. 2016 Nov 8;17(1):167
pubmed: 27821094
World J Nephrol. 2016 Mar 6;5(2):139-46
pubmed: 26981437
Am J Med. 2017 Feb;130(2):163-172.e4
pubmed: 27751901
BMC Nephrol. 2017 Jan 6;18(1):9
pubmed: 28061831
Am J Nephrol. 2012;35(4):349-55
pubmed: 22473149
BMJ. 2012 Oct 04;345:e6341
pubmed: 23036829
Adv Chronic Kidney Dis. 2017 Jul;24(4):194-204
pubmed: 28778358
Am J Nurs. 2008 Sep;108(9 Suppl):58-63; quiz 63
pubmed: 18797231
Nephron Clin Pract. 2012;120(4):c179-84
pubmed: 22890468
Am J Kidney Dis. 2016 May;67(5):742-52
pubmed: 26690912
Eur J Heart Fail. 2011 Aug;13(8):877-84
pubmed: 21693504
Crit Care. 2015 Dec 27;19:443
pubmed: 26707872
Intensive Care Med. 2017 Jun;43(6):855-866
pubmed: 28466146
BMJ. 2018 Nov 28;363:k4895
pubmed: 30487294
Heart. 2019 Jun;105(12):904-910
pubmed: 31118203
Br J Gen Pract. 2011 Jul;61(588):e427-35
pubmed: 21722451
Nat Rev Nephrol. 2017 Apr;13(4):241-257
pubmed: 28239173
J Am Soc Nephrol. 2016 Apr;27(4):1190-200
pubmed: 26264853
World J Nephrol. 2017 Jul 6;6(4):176-187
pubmed: 28729966
Clin J Am Soc Nephrol. 2018 Jun 7;13(6):833-841
pubmed: 29773712
JAMA Intern Med. 2020 Mar 1;180(3):402-410
pubmed: 31985750
PLoS One. 2014 Oct 16;9(10):e109135
pubmed: 25330169